Literature DB >> 10466555

Nosocomial pertussis in healthcare workers from a pediatric emergency unit in France.

J F Gehanno1, M Pestel-Caron, M Nouvellon, J F Caillard.   

Abstract

OBJECTIVE: After pertussis was diagnosed in July 1997 in a 55-year-old nurse (case) from a pediatric emergency unit who had a respiratory illness and paroxysmal cough for 5 weeks, an epidemiological investigation was initiated to determine if other healthcare workers (HCWs) from the same unit also had pertussis.
DESIGN: Interviews were conducted to assess symptoms occurring in the previous months. Two sera were collected 2 to 3 months apart for 59 of 61 HCWs of the unit. The IgG response to pertussis toxin was determined using Western blot assay.
SETTING: Pediatric emergency unit (61 HCWs) of a 2,500-bed university hospital.
RESULTS: There was a total of 10 (5 confirmed and 5 probable) cases of pertussis identified in this outbreak. Nine HCWs (15%) had results suggesting recent or acute pertussis. To avoid transmission to patients and other HCWs, all HCWs with cough were treated for 14 days with erythromycin, and those having acute cough were given a 5-day sick leave. Despite these measures, a new acute pertussis case was identified in a 41-year-old nurse, with a positive culture from nasopharyngeal aspirates. Thus, all HCWs in the unit were prescribed spiramycin for 10 days to prevent any further spread of pertussis.
CONCLUSION: Pertussis should be considered a threat to HCWs who are in contact with children. For HCWs, diagnosis of pertussis should be made on a clinical basis, giving greater importance to sensitivity of diagnosis criteria, and on early bacterial identification by culture of the organism or by polymerase chain reaction. RECOMMENDATIONS: In case of pertussis in an HCW, all staff in the unit who have had unprotected and intensive contact with that person should be provided with macrolide treatment to stop any transmission to colleagues and to young patients. Furthermore, the possibility of providing these HCWs with acellular pertussis vaccines warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10466555     DOI: 10.1086/501667

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  7 in total

Review 1.  Health service careers for people with cystic fibrosis.

Authors:  Sarah Walters
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

2.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 3.  Pertussis vaccination for health care workers.

Authors:  Thomas J Sandora; Courtney A Gidengil; Grace M Lee
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

4.  A comparison of 2 strategies to prevent infection following pertussis exposure in vaccinated healthcare personnel.

Authors:  William P Goins; Kathryn M Edwards; Cindy L Vnencak-Jones; Michael T Rock; Melanie Swift; Valerie Thayer; William Schaffner; Thomas R Talbot
Journal:  Clin Infect Dis       Date:  2012-01-11       Impact factor: 9.079

5.  Shift in the epidemiology of pertussis infection: an indication for pertussis vaccine boosters for adults?

Authors:  Sylvia H Yeh; ChrisAnna M Mink
Journal:  Drugs       Date:  2006       Impact factor: 9.546

6.  Seroprevalence of Pertussis in Healthcare Workers without Adult Pertussis Vaccine Use at a University Hospital in Korea.

Authors:  Won Suk Choi; Su Hyun Kim; Dae Won Park
Journal:  J Korean Med Sci       Date:  2018-11-19       Impact factor: 2.153

7.  Efficacy of face masks and respirators in preventing upper respiratory tract bacterial colonization and co-infection in hospital healthcare workers.

Authors:  C Raina MacIntyre; Quanyi Wang; Bayzidur Rahman; Holly Seale; Iman Ridda; Zhanhai Gao; Peng Yang; Weixian Shi; Xinghuo Pang; Yi Zhang; Aye Moa; Dominic E Dwyer
Journal:  Prev Med       Date:  2014-01-25       Impact factor: 4.018

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.